Yang G. Gu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Deep knowledge-driven multi-modal fusion for diagnosis and prognosis of SI-ARDS.
Journal: Communications medicine
Published: July 10, 2025
A foundational triage system for improving accuracy in moderate acuity level emergency classifications.
Journal: Communications medicine
Published: June 18, 2024
Cortistatin protects against septic cardiomyopathy by inhibiting cardiomyocyte pyroptosis through the SSTR2-AMPK-NLRP3 pathway.
Journal: International immunopharmacology
Published: April 02, 2024
Deep Learning Chest CT for Clinically Precise Prediction of Sepsis-Induced Acute Respiratory Distress Syndrome: A Protocol for an Observational Ambispective Cohort Study.
Journal: Healthcare (Basel, Switzerland)
Published: September 22, 2022
Suitability evaluation of rural sewage treatment facilities in China considering lifcycle environmental impacts and regional differences.
Journal: Journal of environmental management
Published: June 21, 2022
Road runoff as a significant nonpoint source of parabens and their metabolites in urban rivers.
Journal: Chemosphere
Published: January 26, 2022
Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
Journal: JAMA network open
Published: December 08, 2020
Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation.
Journal: Clinical and translational medicine
Published: September 01, 2020
Novel blood-based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non-small-cell lung cancer: Results from two multicenter, randomized clinical trials.
Journal: Clinical and translational medicine
Published: June 09, 2020
Joint association of patients' sex and PD-L1 expression with overall survival benefits and tumor-immune microenvironment in immune checkpoint inhibitors for cancers.
Journal: Clinical and translational medicine
Published: May 18, 2020
The proliferation and invasion of osteosarcoma are inhibited by miR-101 via targetting ZEB2.
Journal: Bioscience reports
Published: July 28, 2018
Last Updated: 09/26/2026